Zoetis Inc. (ZTS) PT Lowered to $238 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ZTS Hot Sheet
Price: $75.84 +3.13%
Rating Summary:
18 Buy, 15 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
18 Buy, 15 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright lowered the price target on Zoetis Inc. (NYSE: ZTS) to $238.00 (from $243.00) while maintaining a Overweight rating.
You May Also Be Interested In
- FDA grants emergency use for Simparica TRIO to treat screwworm in dogs
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
